Xcell Biosciences, a San Francisco-based instrumentation company focused on cell and gene therapy applications, has partnered with Thermo Fisher Scientific Inc. to advance research in regulatory T cells (Tregs) and tumor-infiltrating lymphocytes (TILs). While significant progress has been made in the cell therapy space leveraging Chimeric Antigen Receptor T (CAR T) cells, this collaboration aims to advance Treg and TIL cell therapies that specialize in combating autoimmune and solid tumor dis...